Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
O75529
UPID:
TAF5L_HUMAN
Alternative names:
PCAF-associated factor 65 beta
Alternative UPACC:
O75529; Q5TDI5; Q5TDI6; Q8IW31
Background:
TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L, also known as PCAF-associated factor 65 beta, is a crucial component of the PCAF complex. This complex is known for its efficient acetylation of histones within a nucleosomal context, mirroring the functionality of the yeast SAGA complex. It plays a pivotal role in epigenetic regulation, essential for somatic reprogramming, through H3K9ac deposition and MYC recruitment, orchestrating gene expression programs that maintain the embryonic stem cell state.
Therapeutic significance:
Understanding the role of TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L could open doors to potential therapeutic strategies.